- TWD7.63bn
- TWD4.65bn
- TWD2.33bn
- 98
- 55
- 51
- 83
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,636 | 1,634 | 1,851 | 2,179 | 2,329 |
Cost of Revenue | |||||
Gross Profit | 1,472 | 1,452 | 1,669 | 1,950 | 2,024 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Total Operating Expenses | 1,315 | 1,347 | 1,456 | 1,677 | 1,814 |
Operating Profit | 322 | 287 | 395 | 502 | 515 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 336 | 303 | 407 | 524 | 550 |
Provision for Income Taxes | |||||
Net Income After Taxes | 287 | 256 | 367 | 443 | 452 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 286 | 259 | 370 | 445 | 452 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 286 | 259 | 370 | 445 | 452 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 8.55 | 7.75 | 11.1 | 13.3 | 13.5 |
Dividends per Share |